Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:29 PM
Ignite Modification Date:
2025-12-24 @ 2:29 PM
NCT ID:
NCT02503059
Eligibility Criteria:
Inclusion Criteria:
* Patients with moderate / severe psoriasis (with / without psoriatic arthritis,PAs) defined by: PASI(Psoriasis Area and Severity Index)\> 10 and / or BSA(Body Surface Area)\> 10% and / or DLQI(Dermatology Life Quality Index)\> 10
* PASI\> 10 and / or BSA(Body Surface Area)\> 10% and / or DLQI(Dermatology Life Quality Index)\> 10
* Over 60 years of age at the start of treatment
* Receiving etanercept at any time
* Available history in the Dermatology
Exclusion Criteria:
* Patients with insufficient clinical data in the medical record
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
60 Years
Study:
NCT02503059
Study Brief:
Protocol Section:
NCT02503059